Su2089 RESMETIROM VS SEMAGLUTIDE IN MASH: A REAL-WORLD ASSESSMENT OF CLINICAL OUTCOMES, SAFETY EVENTS, AND BIOCHEMICAL TRAJECTORIES
Regis Lee, Fadi J. Totah, Alex Prevallet, Pejman Solaimani
0 citationsGastrointestinal Endoscopy
Fadi J. Totah
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
5Publications signalées
0Citations signalées
0Affiliations récentes
Domaines associés
Inflammatory Bowel DiseaseDiabetes Treatment and ManagementGastroesophageal reflux and treatmentsColorectal Cancer Treatments and StudiesHyperglycemia and glycemic control in critically ill and hospitalized patients
Publications récentes
Su1827 IMPACT OF GLP-1 RECEPTOR AGONIST THERAPY ON ESOPHAGEAL OUTCOMES IN LEAN AND NON-LEAN PATIENTS WITH GERD
Regis Lee, Nishani Wickramarachchi, Fadi J. Totah, Alex Prevallet et autres
0 citationsGastrointestinal Endoscopy
Tu2160 EXPANDING THE USE OF A NOVEL ENDOSCOPIC ULTRASOUND PLATFORM FOR FNA/FNB IN THE AMBULATORY SURGERY CENTER USING THE ENDOSOUND BIOPSY PORT ADAPTER
Alex Prevallet, Regis Lee, Rowena Feng, Hector Flores-Uribe et autres
0 citationsGastroenterology
Su1827 IMPACT OF GLP-1 RECEPTOR AGONIST THERAPY ON ESOPHAGEAL OUTCOMES IN LEAN AND NON-LEAN PATIENTS WITH GERD
Regis Lee, Nishani Wickramarachchi, Fadi J. Totah, Alex Prevallet et autres
0 citationsGastroenterology
Su2089 RESMETIROM VS SEMAGLUTIDE IN MASH: A REAL-WORLD ASSESSMENT OF CLINICAL OUTCOMES, SAFETY EVENTS, AND BIOCHEMICAL TRAJECTORIES
Regis Lee, Fadi J. Totah, Alex Prevallet, Pejman Solaimani
0 citationsGastroenterology
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.